AI-Designed Enzyme Reverses Decades of Skin Aging Damage in Human Tissue

For decades, the biological "rust" that stiffens our skin, hardens our arteries, and clouds our eyes as we age was considered entirely permanent. Now, scientists have used artificial intelligence to design a custom enzyme that successfully strips this chemical rust out of human tissue. In laboratory tests, the enzyme took 75-year-old skin and restored its flexibility and molecular markers to levels matching a 31-year-old.[1][4]

To understand how this works, think about what happens when you bake a loaf of bread or sear a steak. The heat causes sugars and proteins to bind together, creating a golden-brown crust and rich flavor. This is called the Maillard reaction. Inside your body, the exact same chemical process is happening right now, just at a much slower pace.[2][5]

Baking steadily at 98.6 degrees over decades, the sugars in your bloodstream constantly bump into proteins and fats. When they bind, they create compounds known as Advanced Glycation End-products, or AGEs. As the acronym suggests, these molecules are a primary driver of how we physically age.[2][5]

You can feel the accumulation of AGEs in your own body. They act like a molecular glue, cross-linking the long, elegant fibers of collagen and elastin that keep your tissues supple. When collagen gets cross-linked by AGEs, your skin loses its snap and begins to sag. Your joints feel stiffer in the morning. Your arteries lose their youthful elasticity, forcing your heart to work harder.[3][8]

Until recently, the medical consensus was that once AGEs formed in long-lived tissues, they were there to stay. You could slow their accumulation by wearing sunscreen, managing your blood sugar, and eating fewer highly processed foods, but you could not reverse the damage already done.[2][5]

That assumption changed with a breakthrough published in Nature Communications by researchers at Revel Pharmaceuticals. The team targeted a specific, highly abundant AGE called N-carboxymethyl-lysine, or CML. CML is the stubborn chemical scar that builds up in the extracellular matrix—the scaffolding that holds your cells together.[1][4]

The human body lacks a natural mechanism to break down CML. However, the researchers knew that when we die, our tissues eventually decompose. This meant that somewhere in the natural world, likely within soil microbes, an enzyme existed that could act as a chemical scissor to cut these specific sugar-protein bonds.[1][5]

Instead of spending years manually testing soil samples, the team turned to artificial intelligence. Using AlphaFold—the AI system that predicted the 3D structures of nearly all known proteins—they scanned tens of thousands of microbial DNA sequences.[4][6]

They zeroed in on a family of proteins called glycine oxidases, which had a shape roughly matching the CML molecule. Through AI-guided directed evolution, they tweaked and optimized the protein's structure until it fit the CML bond perfectly. They named their newly engineered enzyme CMLase.[1][5]

When the researchers applied CMLase to 75-year-old human skin tissue in the lab, the results defied decades of biological dogma. The enzyme successfully cleaved the CML bonds, stripping away the accumulated glycation without damaging the underlying collagen fibers.[1][4]

The numbers were striking. The treatment reduced CML levels in the elderly skin tissue by 55 percent. On a molecular level, the extracellular matrix of the 75-year-old tissue was restored to a state healthier and more flexible than typical 31-year-old skin.[1][5]

The implications stretch far beyond the cosmetic appeal of erasing wrinkles. The researchers also applied the enzyme to elderly arterial tissue, achieving a 70 percent reduction in CML, and to eye lens proteins from a 64-year-old donor, reducing the glycation that leads to cataracts by up to 78 percent.[4][7]

If you can clear the chemical rust from the body's scaffolding, you potentially restore the function of the organs themselves. Stripping AGEs from blood vessels could reverse a major underlying cause of hypertension and cardiovascular disease, while clearing them from the brain's vasculature might protect against cognitive decline.[3][8]

However, a petri dish is not a living, breathing human. The challenge now shifts from protein design to safe delivery. Researchers must determine how to transport CMLase deep into living skin or arterial walls without the human immune system recognizing the microbial-derived enzyme as a foreign invader and attacking it.[5][7]

Topical creams and localized injections for skin and joint repair will likely be the first applications tested in clinical trials, as they bypass the complexities of systemic blood delivery. If those prove safe and effective, the next step would be developing therapies to clear glycation from the heart and kidneys.[4][5]

For now, the most actionable takeaway is that the biological clock of our tissues is no longer considered a one-way street. The scaffolding of your body can, in theory, be repaired. Until these enzymatic treatments reach the clinic, your best strategy remains protecting the collagen you have by managing blood sugar and limiting the dietary AGEs found in charred or heavily processed foods.[2][5]